These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 16536058

  • 1. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
    Ohta C, Yamane N, Nakasone I, Onaga S, Nakamura K.
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
    [Abstract] [Full Text] [Related]

  • 2. Antifungal susceptibility of Candida isolates at one institution.
    Katsuragi S, Sata M, Kobayashi Y, Miyoshi T, Yamashita Y, Neki R, Horiuchi C, Yamanaka K, Kamiya C, Iwanaga N, Tanaka H, Ikeda T, Yoshimatsu J.
    Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093
    [Abstract] [Full Text] [Related]

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 4. [In vitro activity of a new semisynthetic echinocandin, micafungin, against clinical isolates of Candida species isolated in Tenri Hospital].
    Komatsu M, Aihara M, Shimakawa K, Iwasaki M, Nagasaka Y, Fukuda S, Abe N, Matsuo S.
    Jpn J Antibiot; 2003 Dec; 56(6):705-11. PubMed ID: 15007879
    [Abstract] [Full Text] [Related]

  • 5. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S.
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [Abstract] [Full Text] [Related]

  • 6. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E, Dambrauskiene A, Vitkauskiene A.
    Medicina (Kaunas); 2006 Feb; 42(4):294-9. PubMed ID: 16687901
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 8. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 9. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
    Samra Z, Yardeni M, Peled N, Bishara J.
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
    [Abstract] [Full Text] [Related]

  • 10. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC.
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [Abstract] [Full Text] [Related]

  • 11. Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
    Kamikawa Y, Mori Y, Nagayama T, Fujisaki J, Hirabayashi D, Sakamoto R, Hamada T, Sugihara K.
    BMC Oral Health; 2014 Feb 20; 14():14. PubMed ID: 24552136
    [Abstract] [Full Text] [Related]

  • 12. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
    Park BJ, Park JC, Taguchi H, Fukushima K, Hyon SH, Takatori K.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):401-5. PubMed ID: 16831406
    [Abstract] [Full Text] [Related]

  • 13. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA, Hoban DJ, Zhanel GG, Goldstein BP.
    Int J Antimicrob Agents; 2006 Feb 25; 27(2):174-7. PubMed ID: 16414247
    [Abstract] [Full Text] [Related]

  • 14. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M, Deshpande LM, Messer SA, Rhomberg PR, Pfaller MA.
    Int J Antimicrob Agents; 2020 Jan 25; 55(1):105799. PubMed ID: 31520783
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
    Pfaller MA, Arikan S, Lozano-Chiu M, Chen Y, Coffman S, Messer SA, Rennie R, Sand C, Heffner T, Rex JH, Wang J, Yamane N.
    J Clin Microbiol; 1998 Sep 25; 36(9):2609-12. PubMed ID: 9705401
    [Abstract] [Full Text] [Related]

  • 16. Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
    Pai MP, Samples ML, Mercier RC, Spilde MN.
    Antimicrob Agents Chemother; 2008 Jul 25; 52(7):2367-76. PubMed ID: 18426896
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
    Guo LN, Xiao M, Cao B, Qu F, Zhan YL, Hu YJ, Wang XR, Liang GW, Gu HT, Qi J, Yuan H, Min R, Wang FY, Liu LJ, Wang HB, Jiang W, Duan XG, Xu WJ, Yu YH, Su JR, Zhang JZ, Nong JQ, Liu SM, Li J, Liu JT, Yue ZG, Yang D, Guo J, Zhao R, Zhang YN, Yang XM, Liu XQ, Hsueh PR, Xu YC.
    Future Microbiol; 2017 Sep 25; 12():1075-1086. PubMed ID: 28836465
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.
    Arikan S, Sancak B, Hascelik G.
    Med Mycol; 2005 Mar 25; 43(2):171-8. PubMed ID: 15832560
    [Abstract] [Full Text] [Related]

  • 19. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA, Castanheira M, Messer SA, Jones RN.
    Mycoses; 2015 Apr 25; 58(4):209-14. PubMed ID: 25727853
    [Abstract] [Full Text] [Related]

  • 20. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E, Hammarström H, Ataollahy N, Kondori N.
    Sci Rep; 2019 Mar 07; 9(1):3838. PubMed ID: 30846717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.